How will the Inflation Reduction Act combat rising drug prices? Why are pharmaceutical companies fighting back? In 2022, President Biden signed into law the Inflation Reduction Act, which aims, among other things, to reduce spending by Medicare on prescription drugs. The pharmaceutical industry has launched a series of lawsuits to stop the act from taking effect. In this article, we’ll examine the context that brought about the new law and the pharmaceutical industry’s opposition.
The Inflation Reduction Act (IRA) vs. Rising Drug Prices










